Conmed Corporation · NYSE:CNMD
Conmed — Q3 2020 Earnings Presentation
8 slides from Conmed's earnings presentation, Oct 28, 2020
Slide 1: Investor Presentation
Investor Presentation Curt R. Hartman President, Chief Executive Officer and Chair of the Board Todd Garner Executive Vice President & Chief Financial Officer October 28, 2020
Slide 2: Forward-Looking Information
Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 199
Slide 3: CONMED Vision
CONMED Vision Empower healthcare providers worldwide to deliver exceptional outcomes for patients. Focus behind the Vision People Products Enhancing profitability 3
Slide 4: Objectives for Our Shareholders
Objectives for Our Shareholders ▪ Aggregate growth and profitability over the long term to significantly increase the valuation of the company ▪ Increase our market share in large and attractive markets ▪ Deliver above-market revenue and profitability growth over the long term 4
Slide 5: Q3 2020 Results
Q3 2020 Results ▪ Revenue: $237.8M, an increase of 1.8% year over year as reported and in constant currency ▪ GAAP EPS: Diluted net earnings per share of $0.23, compared to diluted net earnings per share of $0.23 in the third quarter of 2019 ▪ Adjusted EPS1: Diluted net earnings per share of $0.88,
Slide 6: Orthopedics: Large, Attractive Markets
Orthopedics: Large, Attractive Markets Category Description Market Size and Competitors Dollar Value of 1 Market Share Point $4.4 to $4.6 Billion Sports Devices for repair of soft ▪ Arthrex ~$45M Full-Year 2019 Medicine tissue injuries in joints ▪ DePuy Mitek (J&J) ▪▪ Stryker Zimmer Biomet ▪ Smith &
Slide 7: General Surgery: Large, Attractive Markets
General Surgery: Large, Attractive Markets Dollar Value of 1 Market Category Description Market Size and Competitors Share Point $1.4 to $1.6 Billion A platform of devices and accessories to ▪ Ethicon (J&J) ▪ Medtronic Full-Year 2019 Access create and enter the surgical working space ▪ Applied ▪ Oly
Slide 8: Closing Thoughts
Closing Thoughts ▪ Intense focus on the healthcare customer and solving their unmet needs drives increased market share ▪ Large and attractive markets provide CONMED with ample opportunities for above-average revenue and profitability growth ▪ Aggregating that growth over the long term can drive mea